{
    "Case ID": "006969",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement dispute"
    ],
    "Legal_Issue": [
        "Whether Nu-Pharm's process is an obvious chemical equivalent of the '151 patent"
    ],
    "Governing_Law": [
        "Patented Medicines (Notice of Compliance) Regulations, s. 6"
    ],
    "Procedural_Stage": [
        "Pre-trial application for prohibition order"
    ],
    "Evidence_Assessment": [
        "Affidavits, cross-examinations, and patent documents were analyzed; evidence showed acetone not essential for industrial-scale production"
    ],
    "Decision_Outcome": [
        "Abbott's application for a prohibition order was granted"
    ],
    "Burden_of_Proof": [
        "On Abbott to justify allegations of non-infringement based on assumed or proven facts"
    ],
    "Credibility_Factor": [
        "Evidence from affidavits and cross-examinations assessed for reliability"
    ],
    "Legal_Rule": [
        "A court must determine if allegations of non-infringement are justified under s. 6 of the Patented Medicines (NOC) Regulations"
    ],
    "Standard_of_Review": [
        "Based on facts assumed or proven at the time of the patent"
    ],
    "Procedural_Issue": [
        "Determination of infringement prior to regulatory approval"
    ],
    "Grounds_for_Claim": [
        "Nu-Pharm’s process alleged to be an obvious chemical equivalent of the patented process"
    ],
    "Outcome_on_Merits": [
        "Claim of infringement upheld; Nu-Pharm prohibited from proceeding until patent expiry"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Prohibition order granted in favor of Abbott"
    ],
    "Review_Standard": [
        "Objective assessment of chemical equivalence under existing knowledge"
    ],
    "Procedural_Fairness_Assessment": [
        "Parties had opportunity to present evidence and be heard"
    ],
    "Key_Evidence_Considered": [
        "Chemical process details, temperature variations, use or omission of acetone, scalability without acetone"
    ],
    "Legal_Framework": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Applicant_Challenge": [
        "Abbott challenged Nu-Pharm’s regulatory submission as infringing"
    ],
    "Court_Result": [
        "Injunction granted preventing Nu-Pharm from obtaining marketing approval"
    ],
    "Legal_Rule_Source": [
        "Statutory: s. 6 of the Patented Medicines (NOC) Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Nu-Pharm argued their process differed by using higher temperatures and no acetone"
    ],
    "Evidence_Type": [
        "Documentary evidence, expert affidavits, cross-examination transcripts"
    ],
    "Remedy_Requested": [
        "Prohibition order to block regulatory approval"
    ],
    "Outcome": [
        "Remedy granted; Nu-Pharm barred until patent expiration"
    ],
    "Decision_Authority": [
        "Federal Court (implied by NOC proceeding context)"
    ],
    "Remedy_Sought": [
        "Interlocutory injunction preventing market entry"
    ],
    "Resolution_Mechanism": [
        "Summary judgment based on affidavit evidence"
    ],
    "Legal_Provision": [
        "s. 6, Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Canadian Federal Court"
    ],
    "Claimant_Status": [
        "Patent holder (Abbott)"
    ],
    "Legal_Provision_Cited": [
        "s. 6 of the Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Allegation of infringement based on obvious chemical equivalence"
    ],
    "Applicable_Process": [
        "NOC proceeding under Canadian patent law"
    ],
    "Outcome_of_Review": [
        "Application allowed; prohibition imposed"
    ],
    "Pending_Relief_or_Application": [
        "Application for prohibition order under NOC Regulations"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "s. 6, Patented Medicines (Notice of Compliance) Regulations"
    ]
}